Doma Perpetual Capital Management LLC Has $13.91 Million Stock Holdings in Afya Limited $AFYA

Doma Perpetual Capital Management LLC grew its holdings in shares of Afya Limited (NASDAQ:AFYA) by 50.6% during the 3rd quarter, HoldingsChannel reports. The institutional investor owned 891,639 shares of the company’s stock after purchasing an additional 299,419 shares during the period. Afya comprises approximately 4.7% of Doma Perpetual Capital Management LLC’s holdings, making the stock its 7th largest holding. Doma Perpetual Capital Management LLC’s holdings in Afya were worth $13,910,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of AFYA. Goldman Sachs Group Inc. grew its holdings in shares of Afya by 167.3% in the 1st quarter. Goldman Sachs Group Inc. now owns 45,093 shares of the company’s stock valued at $809,000 after acquiring an additional 28,226 shares in the last quarter. Geode Capital Management LLC raised its holdings in Afya by 85.1% during the second quarter. Geode Capital Management LLC now owns 52,111 shares of the company’s stock worth $931,000 after acquiring an additional 23,961 shares in the last quarter. Dynamic Technology Lab Private Ltd acquired a new position in Afya during the second quarter valued at approximately $391,000. Quadrature Capital Ltd bought a new position in Afya in the second quarter valued at approximately $181,000. Finally, Quantbot Technologies LP acquired a new position in shares of Afya during the 2nd quarter worth approximately $117,000. 88.02% of the stock is currently owned by institutional investors and hedge funds.

More Afya News

Here are the key news stories impacting Afya this week:

• Positive Sentiment: EPS beat — Afya reported $0.41 EPS for 4Q25, topping consensus estimates and last year’s EPS, signaling stronger profitability per share which supports valuation metrics. Afya (AFYA) Tops Q4 Earnings Estimates
• Positive Sentiment: Large cash return — the Board approved a R$307.4 million dividend (~40% of consolidated net income), which is supportive for income-focused shareholders and may attract yield-seeking demand. Afya Limited Announces Dividend Distribution of R$307.4 Million
• Neutral Sentiment: Management commentary/transcript available — the full Q4 2025 earnings call transcript provides additional color on growth drivers, margins and capital allocation; investors should review management’s remarks on enrollment trends and clinic operations. Afya Limited (AFYA) Q4 2025 Earnings Call Transcript
• Negative Sentiment: Revenue miss — Afya reported 4Q revenue of BRL147.08 million (reported in USD-equivalent headlines), materially below analyst expectations, raising questions about enrollment or service revenue pacing that could pressure near-term growth. Afya Limited Announces Fourth Quarter and Twelve Months 2025 Financial Results
• Negative Sentiment: FY‑2026 revenue guidance slightly below consensus — the company updated FY‑2026 revenue guidance to a range (~R$731.7M–R$759.5M in the entry) that sits under the street’s ~$764M consensus, introducing downside risk to growth expectations; EPS guidance detail was unclear in the release. Afya Limited Announces Fourth Quarter and Twelve Months 2025 Financial Results

Afya Trading Up 1.9%

AFYA stock opened at $13.76 on Monday. Afya Limited has a one year low of $13.00 and a one year high of $19.90. The stock has a market cap of $1.29 billion, a price-to-earnings ratio of 9.42, a price-to-earnings-growth ratio of 0.61 and a beta of 0.52. The company has a fifty day moving average price of $14.39 and a two-hundred day moving average price of $14.76. The company has a debt-to-equity ratio of 0.21, a current ratio of 2.20 and a quick ratio of 0.98.

Afya (NASDAQ:AFYA) last released its quarterly earnings results on Thursday, March 12th. The company reported $0.41 earnings per share for the quarter, beating the consensus estimate of $0.36 by $0.05. Afya had a net margin of 20.31% and a return on equity of 18.77%. The firm had revenue of $147.08 million for the quarter, compared to analysts’ expectations of $174.74 million. Equities analysts anticipate that Afya Limited will post 1.52 EPS for the current year.

Analyst Upgrades and Downgrades

AFYA has been the topic of a number of analyst reports. Bank of America cut Afya from a “buy” rating to a “neutral” rating and dropped their price objective for the stock from $22.00 to $17.00 in a research note on Tuesday, February 24th. Wall Street Zen upgraded shares of Afya from a “buy” rating to a “strong-buy” rating in a report on Saturday. JPMorgan Chase & Co. reaffirmed a “neutral” rating and issued a $22.00 target price (down from $24.50) on shares of Afya in a report on Wednesday, January 7th. Sanford C. Bernstein upgraded Afya to a “market perform” rating in a report on Friday, January 16th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Afya in a research report on Wednesday, January 21st. One analyst has rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Afya has an average rating of “Hold” and a consensus target price of $17.30.

About Afya

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.